Medivir announces departure of Chief Medical Officer
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that Linda Basse, Chief Medical Officer at Medivir will leave the company on September 30, 2020. A recruitment process to find a new Chief Medical Officer will be initiated. For further information, please contact:Uli Hacksell, CEO, Medivir AB, phone: +46 (0)8 5468 3100. About MedivirMedivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The company is investing in indication areas where available therapies are limited or missing and there are great opportunities